company? Let’s change
that.
Don't see your company?
Create a company profileA pioneering clinical stage startup company leading the Cell & Gene therapy revolution and are committed to bringing breakthrough cancer treatment to patients in India, making it accessible & affordable.
Mynvax is a pre-clinical stage vaccine biotechnology. Current develop programs include a recombinant vaccine for human influenza and COVID19.
Cytiva, now with the life sciences business from Pall Corporation, is a global life sciences leader dedicated to helping customers discover and commercialize the next generation of therapeutics. Together, we bring dedicated technical expertise and a broad portfolio of tools and technologies that enable the development, manufacture, and delivery of transformative medicines to patients. Visit cytiva.com to learn more.
At Sayre Therapeutics, we focus on bringing hitherto unavailable novel medicines, drug-delivery devices, companion diagnostics and diagnostic imaging agents to medical oncologists, surgical oncologists, radiation oncologists, interventional radiologists and rheumatologists.These include, but are not limited to, small molecules, recombinant proteins,monoclonal antibodies (mAbs),drug-delivery devices and diagnostics in Oncology and Immunology.Our business model encompasses Global access / early access programs, Named Patient programs and securing product registrations for exclusive commercial distribution in South Asia.
Greetings from OncoStem ! We are glad you landed on our page. Who are we ? Cancer is a complex disease, and we at OncoStem develop tests that help to identify patterns of cancer recurrence risk. An understanding of these patterns ensures that patients receive personalized therapies and treatments that are best suited to their condition. Founded in 2011, OncoStem aims to develop innovative tests to personalize treatment for cancer patients. Understanding of tumor biology aids physicians in optimizing therapy for cancer patients. Our flagship product CanAssist Breast has been launched for hormone-positive breast cancer. Currently, we are working on similar tests for other cancer types including triple-negative breast cancer and ovarian cancer. Research is underway towards identifying and characterizing novel drug targets for breast and ovarian cancer. We would love to connect with you :)
Kemwell is a contract biologics development and CMO company providing services to global biopharmaceutical organizations. Kemwell facilities, located in Bangalore, India, are designed and developed with technological support from a leading German pharma company. Kemwell provides customers with cost-effective access to state-of-the-art technology for all mammalian cell culture based products’ development and manufacturing.